Gigi Davidson, R.Ph., DICVP, Chair of USP's Compounding Expert Committee shares her thoughts and background information on proposed revisions to <797> Pharmaceutical Compounding—Sterile Preparations. Compounding practitioners are encouraged to view and share comments on the changes online.
Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field.
Compounding plays a critical role in treating and preventing disease when commercially available medicine is unsuitable. USP has developed standards for compounding practitioners since 1820, and presently provides three types of standards to help ensure quality compounded medicines.